AzTrials
AzTrials

Labor, InducedNCT04731896

Early Versus Late Amniotomy During Labor Induction in Women With Bishop's Score of ≥ 6

A study testing Amniotomy in people with Labor, Induced and Amniotomy, run by University Tunis El Manar at 1 site in Tunisia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Labor induction is the stimulation of uterine contractions during pregnancy, before labor begins on its own to achieve a vaginal birth. A health care provider might recommend labor induction for various reasons: primarily when there's concern for a mother's health or a baby's health. Read more about this study

Who is it for?
Ages 18 to 48 years, women onlyHealthy volunteers can take part
Conditions the study is for
Labor, Induced, Amniotomy
What is being tested?
Amniotomy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteTunisia
Study dates
8 Feb 2021to 31 Dec 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 48 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Age ≥ 18 years old
  • Full term (36 weeks and 3 days of gestation reached)
  • Singletion gestation in cephalic presentation
  • Bishop score of ≥ 6

Who cannot join

  • Prior uterine surgery, previous cesarean section
  • Ruptured membranes
  • Spontaneous labor
  • Multifetal pregnancy
  • Dystocic presentation
  • Fetal head not fixed at pelvic brim
Show all 13Show fewer
  • Macrosomia
  • Hydramnios
  • Severe fetal growth restriction
  • Major fetal anomaly
  • Women with HIV, hepatitis C, hepatitis B
  • Women with medical conditions contraindication to a vaginal delivery
  • Women with COVID-19 infection

Trial locations and contacts

1 site in 1 country.

Tunisia1 site
  • University hospital Mongi Slim la Marsa

    Tunis, La Marsa, 2046

Other trials in Tunisia

About this study

Official title: Early Versus Late Amniotomy During Labor Induction in Women With Bishop's Score of ≥ 6 : a Randomized Trial

Labor induction is the stimulation of uterine contractions during pregnancy, before labor begins on its own to achieve a vaginal birth.

A health care provider might recommend labor induction for various reasons: primarily when there's concern for a mother's health or a baby's health.

Combined with oxytocin infusion, amniotomy is commonly used in the induction of labor. However the perfect timing of amniotomy is still unknown.

The aim of this study is to determine whether the early amniotomy followed by oxytocin, or initiating induction of labor with oxytocin followed by late amniotomy, is effective to reach active phase of labor.

Being tested
Amniotomy
Keywords
labor, Amniotomy, induction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • AmniotomyProcedure or surgery

    artificial rupture of the amniotic sac

Study groups in NCT04731896
Study groupRoleWhat they receive
Late AmniotomyNo interventionInitiating induction of labor with oxytocin infusion followed by amniotomy 4-6 hours later
Early AmniotomyActive comparatorEarly amniotomy initiating induction of labor followed by oxytocin infusion 30 minutes later
Receives: Procedure: Amniotomy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time to active phase of labor

    Total time from initiation oxytocin infusion to reaching 5 cm cervical dilation

    Measured: At delivery

Secondary outcomes (4)
  1. Cesarean delivery rate

    Rate of cesarean section

    Measured: At delivery

  2. Time to vaginal delivery

    Total time from initiation of labor induction to vaginal delivery

    Measured: At delivery

  3. Maternal outcomes

    Intrapartum and postpartum fever, postpartum haemorrhage, chorioamnionitis, endometritis

    Measured: From inclusion to discharge, up to 2 weeks

  4. Fetal and neonatal outcome

    Fetal distress, birth asphyxia, acidosis, sepsis

    Measured: From inclusion to discharge, up to 2 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Feb 2021
  2. Study start8 Feb 2021
  3. Primary completion30 Sep 2021
  4. Study completion31 Dec 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
100 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04731896
Sponsor's protocol ID
UTuniselmanar2
Status last verified
Sep 2022
First submitted
26 Jan 2021
Last updated
28 Sep 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Questions about this trial

What is this clinical trial studying?

A study testing Amniotomy in people with Labor, Induced and Amniotomy, run by University Tunis El Manar at 1 site in Tunisia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 28 Sep 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Tunisia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time to active phase of labor (time frame: At delivery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Sep 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in